GL1X · GenesisL1 explorer

MolNFT v1 · #135733 · protein

Identification of a new class of potent CDC7 inhibitors designed by putative pharmacophore model: synthesis and biological evaluation of 2,3-DIHYDROTHIENO[3,2-D]PYRIMIDIN-4(1H)-ones

5U7Q: “Identification of a new class of potent CDC7 inhibitors designed by putative pharmacophore model: synthesis…”. X-ray diffraction. MolNFT v1 #135733 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5U7Q
Type
protein
Length
1,546 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
O75116

Structure

x-ray diffraction · 4 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein388—O75116
B—protein385—O75116
C—protein390—O75116
D—protein383—O75116

Compared structures

  • 5U7Q · Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative… · the same entry in another collection · chain D against D, TM-score 1.00
  • O75116 · AlphaFold monomer V2.0 prediction for rho-associated protein kinase 2 (O75116) · a predicted model of the same protein · chain D against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.